NANOCARRY

Nanocarry is developing a new class of brain therapeutics, which combines biological approaches with nanoparticles to allow biologics to cross the Blood Brain Barrier, creating first-in-class therapeutics for neuro-oncology indications and CNS diseases... Nanocarry is developing an innovative delivery technology platform pioneered over the past decade in the Nano-Bioengineering lab of Prof. Rachela Popovtzer at Bar Ilan University, Israel. With pre-seed financing from NfX and TechBio, Nanocarry's nano-chemistry and biology labs are working synergistically to develop first-in-class product candidates, while scaling and optimizing the manufacturing process of its bioengineered gold nanoparticles... Our proprietary technology platform's Plug & Play approach offers infinite possibilities. The rise of biologics over the last 20 years has revolutionized disease treatment; however, 1 in 6 people worldwide are living with a neurological condition and patients with brain diseases are being..

Also known as: Nanocarry Therapeutics